Phase II trial of sorafenib in patients with advanced thyroid cancer

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 29; no. 15_suppl; p. 5562
Main Authors Keefe, S. M., Troxel, A. B., Rhee, S., Puttaswamy, K., O'Dwyer, P. J., Loevner, L. A., Mandel, S. J., Brose, M. S.
Format Journal Article
LanguageEnglish
Published 20.05.2011
Online AccessGet full text

Cover

Abstract Abstract only
AbstractList Abstract only
Author Rhee, S.
Mandel, S. J.
Brose, M. S.
Keefe, S. M.
Troxel, A. B.
O'Dwyer, P. J.
Puttaswamy, K.
Loevner, L. A.
Author_xml – sequence: 1
  givenname: S. M.
  surname: Keefe
  fullname: Keefe, S. M.
– sequence: 2
  givenname: A. B.
  surname: Troxel
  fullname: Troxel, A. B.
– sequence: 3
  givenname: S.
  surname: Rhee
  fullname: Rhee, S.
– sequence: 4
  givenname: K.
  surname: Puttaswamy
  fullname: Puttaswamy, K.
– sequence: 5
  givenname: P. J.
  surname: O'Dwyer
  fullname: O'Dwyer, P. J.
– sequence: 6
  givenname: L. A.
  surname: Loevner
  fullname: Loevner, L. A.
– sequence: 7
  givenname: S. J.
  surname: Mandel
  fullname: Mandel, S. J.
– sequence: 8
  givenname: M. S.
  surname: Brose
  fullname: Brose, M. S.
BookMark eNo10NtKxDAUBdAgIzgz-g_xA1pzaZrmUcZbYUAfFHwLZ3KhGWpTkqrM39uiPh02HDabtUGrIQ4OoWtKSsoIuTmaWDJCaclUSYXOn-PYl0LU7AytqWCykFKIFVoTyVlBG_5-gTY5HwmhVcPFGt29dJAdbls8pQA9jh7nmMC7IRxwGPAIU3DDlPF3mDoM9gsG4yyeulOKwWKzxHSJzj302V393S16e7h_3T0V--fHdne7LwwlNSuMsNW8GcASaCwDJ4yYt8sD4aS2yltTW-YbJiopOTAHqja85vOfEtZ5y7dI_faaFHNOzusxhQ9IJ02JXjj0zKEXDs2U_ufQCwf_ATsTWPo
CitedBy_id crossref_primary_10_1186_s12885_019_6369_7
crossref_primary_10_1007_s00106_011_2464_z
crossref_primary_10_1177_1758834014548188
crossref_primary_10_3310_hta24020
crossref_primary_10_1016_j_semcancer_2020_11_013
crossref_primary_10_1007_s11523_015_0363_z
crossref_primary_10_1097_CCO_0000000000000029
crossref_primary_10_1590_0004_2730000002839
crossref_primary_10_3390_ijms16036153
crossref_primary_10_3390_ijms23105731
crossref_primary_10_5306_wjco_v13_i1_9
crossref_primary_10_1586_eem_12_36
crossref_primary_10_1586_era_12_96
ContentType Journal Article
DBID AAYXX
CITATION
DOI 10.1200/jco.2011.29.15_suppl.5562
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1527-7755
EndPage 5562
ExternalDocumentID 10_1200_jco_2011_29_15_suppl_5562
GroupedDBID ---
.55
0R~
18M
2WC
34G
39C
3O-
4.4
53G
5GY
5RE
8F7
AARDX
AAWTL
AAYEP
AAYOK
AAYXX
ABJNI
ABOCM
ACGFO
ACGFS
ACGUR
ADBBV
AEGXH
AENEX
AFFNX
AI.
AIAGR
ALMA_UNASSIGNED_HOLDINGS
AWKKM
BAWUL
C45
CITATION
CS3
DIK
EBS
EJD
F5P
F9R
FBNNL
FD8
GX1
H13
HZ~
IH2
KQ8
L7B
LSO
MJL
N9A
O9-
OK1
OVD
OWW
P2P
QTD
R1G
RHI
RLZ
RUC
SJN
SV3
TEORI
TR2
TWZ
UDS
VH1
VVN
WH7
X7M
YCJ
YFH
YQY
ID FETCH-LOGICAL-c1062-c5d4200aad0a8d2ae5c52017b0306d9fdc6d2f8254773a2ea96c363ae595defd3
ISSN 0732-183X
IngestDate Fri Aug 23 02:51:07 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 15_suppl
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1062-c5d4200aad0a8d2ae5c52017b0306d9fdc6d2f8254773a2ea96c363ae595defd3
PageCount 1
ParticipantIDs crossref_primary_10_1200_jco_2011_29_15_suppl_5562
PublicationCentury 2000
PublicationDate 2011-05-20
PublicationDateYYYYMMDD 2011-05-20
PublicationDate_xml – month: 05
  year: 2011
  text: 2011-05-20
  day: 20
PublicationDecade 2010
PublicationTitle Journal of clinical oncology
PublicationYear 2011
SSID ssj0014835
Score 2.045976
Snippet Abstract only
SourceID crossref
SourceType Aggregation Database
StartPage 5562
Title Phase II trial of sorafenib in patients with advanced thyroid cancer
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtNAEF2FIlW8ICggKBctEuqLa-OsvXb9SMulARVFKJXyZs3e1CDVRokjKL_ATzObXV9KQUBfrGSVHHl9jmZnx7MzhLwAYWQ-FjxM1di2MAMRCgEsTAHQ28jAuhU22-Jjdnyavp_z-Wj0Y5C1tG5EJL__9lzJdVjFMeTVnpL9D2Y7UBzAz8gvXpFhvP4Tx9MzXIOCySRwvTfQ71sho0ZXCxH0NVPbA2zt236kZlkvlM33kj4396p32p2YrCt5KfL-QWvjwtZRcBJ1G_9l_c2_74-Cw27405mvw9-NTNdNA6uvcO7SBaJh1MGGUXnI4oFxyhMWojmYu3XEG0-Wo7fuyu621tXHM7yKeLmyzUoHFpNzb431pa9XLDvbNK3-LGtXdpUVUQsW9RDDatq_rHJd7qHd9SBYiVClhSpZUbZQpYW6QW4ytFo2P_DdvMsXwm2j69baTnybPPf39fKPdzVwdgZey-wOue0Jpa-cdu6Ska52yPaJT6jYIXtTV7r8Yp_O-pN4q326R6d9UfOLe-T1Rmt0MqEbrdHa0E5rdFHRVmvUao22WqNea9Rp7T45fftmdnQc-g4coRzHGQslVylOEEDFcKAYaC45TjQXdqepCqNkppixQYY8T4BpKDKZZAn-ruBKG5U8IFtVXemHhBrQCjIB8gDi1PBY5AWiZ8W4QFx8uo8Iax9V-cUVWin_StXudf70mNzqFf2EbDXLtX6KnmUjnm0Y_wkC7XeV
link.rule.ids 315,783,787,27938,27939
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Phase+II+trial+of+sorafenib+in+patients+with+advanced+thyroid+cancer&rft.jtitle=Journal+of+clinical+oncology&rft.au=Keefe%2C+S.+M.&rft.au=Troxel%2C+A.+B.&rft.au=Rhee%2C+S.&rft.au=Puttaswamy%2C+K.&rft.date=2011-05-20&rft.issn=0732-183X&rft.eissn=1527-7755&rft.volume=29&rft.issue=15_suppl&rft.spage=5562&rft.epage=5562&rft_id=info:doi/10.1200%2Fjco.2011.29.15_suppl.5562&rft.externalDBID=n%2Fa&rft.externalDocID=10_1200_jco_2011_29_15_suppl_5562
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0732-183X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0732-183X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0732-183X&client=summon